特宝生物股价跌1.08%，金元顺安基金旗下1只基金重仓，持有1.64万股浮亏损失1.47万元

Group 1 - The core point of the news is that TeBao Bio's stock price has decreased by 1.08%, currently trading at 82.71 yuan per share, with a total market capitalization of 33.76 billion yuan [1] - TeBao Bio, established on August 7, 1996, and listed on January 17, 2020, is primarily engaged in the research, production, and sales of recombinant proteins and long-acting modified drugs [1] - The company's main business revenue composition includes antiviral drugs at 86.85%, blood/cancer drugs at 12.87%, and other (supplementary) at 0.27% [1] Group 2 - From the perspective of fund holdings, Jin Yuan Shun An Fund has one fund heavily invested in TeBao Bio, specifically the Jin Yuan Shun An Value Growth Mixed Fund (620004), which held 16,400 shares, accounting for 1.97% of the fund's net value [2] - The Jin Yuan Shun An Value Growth Mixed Fund has a current scale of 70.05 million yuan, with a year-to-date return of 19.37% and a one-year return of 17.03% [2] - The fund manager, Kong Xiangpeng, has been in position for 8 years and 189 days, while Han Chenyang has been in position for 2 years and 307 days, with respective best and worst fund returns during their tenure [2]